B, N. H. (2021) “The Thromboembolism and Bleeding Event in Patients Receiving Warfarin, Dabigatran, or Rivaroxaban in Nonvalvular Atrial Fibrillation”, PHARMACY: Jurnal Farmasi Indonesia (Pharmaceutical Journal of Indonesia), 18(2), pp. 453–459. doi: 10.30595/pharmacy.v18i2.13315.